top of page
Experienced strategic partners, helping you tell your story

Biotech and

life sciences expertise

Investor relations that build

credibility and unlock capital

Wall Street insights that guides

leaders through defining moments

We focus on your
strategy

What you say

communications

How you say it

investor relations

Who you say it to

ABOUT US
Decades of Life Sciences and
Wall Street Experience

Investor insight

Biotech expertise

Strategic experience

Trusted counsel

matt-lane-1024x1024.jpg

Matt Lane

Principal and Founder

sara-michelmore-1024x1024.jpg

Sara Michelmore

Managing Director

john-mitchell-1024x1024.jpg

John Mitchell

Managing Director

SERVICES
Tailored Solutions for Any Stage of Growth

Strategic communications and investor relations for life sciences.

Building and sustaining credibility with investors.

Milestone image-05_edited.jpg
Private
Companies

From private rounds to the public markets, we help you build a compelling story, and navigate the IPO process with confidence.

Milestone image-04.png
Public Markets
and Beyond

Strengthen long-term credibility with investors and analysts. Adapt your story to sustain trust and build momentum through growth, partnerships, and market cycles.​​

Messaging and Content Creation

Investor Engagement and Strategy

Industry and Capital Markets Insights

IPO Transaction Preparedness and S-1 Drafting

Roadshow and Analyst Day Preparation

Capital Markets Counsel and Navigation

Ongoing Investor Relations and Analyst Engagement

Market Intelligence

Thought Leadership and Executive Visibility

High-Stakes Communications for Biotech and Life Sciences

Strategic Pivots and Special Situations

CASE STUDIES
Proven Results for Our Clients

Sharper stories, stronger credibility, better access to capital.

Private Company Financing Reset

Private Company Messaging Overhaul

Preclinical Proof-of-Concept Support

Road to IPO

Public Company Pivot

BLOG
Practical Perspective on the Life Sciences Market

Grounded commentary and guidance for life sciences leaders navigating today’s market.

October 16, 2025

Biotech Industry Insight - Green Shoots, Same High Bar

Why optimism is returning, but only disciplined stories are getting funded?

November 2, 2022

The Rules Have Changed

Innovative treatments are making meaningful strides against some of the largest unmet needs across medicine at the same time pharma has its greatest ever pressure to replenish pipelines with new products.

Technology-Background-with-Flowing-Lines-and-Light-Particles-2216163156_7040x3960_edited.j
CONTACT
Let’s Talk About
How We Can Help You

Our engagements are partner-led and tailored. Get in touch to start the conversation.

info@milestone-advisorsllc.com

bottom of page